Patent details

EP1071422 Title: Association of Riluzole and levodopa for the treatment of Parkinson disease

  • Data
  • Documents

Basic Information

Publication number:
EP1071422
PCT Application Number:
PCT/FR/1999/000953
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP999158090
PCT Publication Number:
WO/1999/055336
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
Association of Riluzole and levodopa for the treatment of Parkinson disease
French Title of Invention:
ASSOCIATIONS DE RILUZOLE ET DE LEVODOPA POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON
German Title of Invention:
KOMBINATION VON RILUZOL UND LEVODOPA ZUR BEHANDLUNG VON MORBUS PARKINSON
SPC Number:

Dates

Filing date:
22/04/1999
Grant date:
20/02/2008
EP Publication Date:
20/02/2008
PCT Publication Date:
04/11/1999
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2001
EP B1 Publication Date:
20/02/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/04/2014
Expiration date:
22/04/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/04/1999
 
 

Name:
Aventis Pharma S.A.
Address:
20, avenue Raymond Aron, 92160 Antony, France (FR)

Inventor

1

Name:
IMPERATO Assunta
Address:
France (FR)

2

Name:
BLANCHARD-BREGEON Véronique
Address:
France (FR)

3

Name:
REIBAUD Michel
Address:
France (FR)

4

Name:
MOUSSAOUI Saliha
Address:
France (FR)

5

Name:
OBINU Marie-Carmen
Address:
France (FR)

Priority

Priority Number:
9805153
Priority Date:
24/04/1998
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 31/428;